Devgen receives IWT grant to support its obesity drug discovery program
Devgen has been awarded a 0.9 million Euro technology grant from the Flanders government through IWT (Institute for the Promotion of Innovation by Science and Technology in Flanders) to develop new targets and therapeutic solutions for the treatment of obesity.
In its obesity program, Devgen takes a multidisciplinary approach to validate a novel class of kinase targets. According to the company, IWT's support for this program is very important for Devgen, not only from a funding perspective, but it is an endorsement of the innovative approach and validation opportunities of this program. The funding covers a period of 16 months.
Most read news
Other news from the department science

New Label-Free Imaging Tracks Cancer Treatment in Single Cells
One Tool, Many Applications

The evolution of cancer cells decoded
"Our vision is a new type of early cancer detection"

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.